133 related articles for article (PubMed ID: 22349513)
1. KLF10, transforming growth factor-β-inducible early gene 1, acts as a tumor suppressor.
Song KD; Kim DJ; Lee JE; Yun CH; Lee WK
Biochem Biophys Res Commun; 2012 Mar; 419(2):388-94. PubMed ID: 22349513
[TBL] [Abstract][Full Text] [Related]
2. KLF10 affects pancreatic function via the SEI-1/p21Cip1 pathway.
Wu MJ; Wu WC; Chang HW; Lai YT; Lin CH; Yu WC; Chang VH
Int J Biochem Cell Biol; 2015 Mar; 60():53-9. PubMed ID: 25578559
[TBL] [Abstract][Full Text] [Related]
3. Zac1, an Sp1-like protein, regulates human p21(WAF1/Cip1) gene expression in HeLa cells.
Liu PY; Hsieh TY; Liu ST; Chang YL; Lin WS; Wang WM; Huang SM
Exp Cell Res; 2011 Dec; 317(20):2925-37. PubMed ID: 22001409
[TBL] [Abstract][Full Text] [Related]
4. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
6. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
7. Loss of p21CIP1/WAF1 does not recapitulate accelerated malignant conversion caused by p53 loss in experimental skin carcinogenesis.
Weinberg WC; Montano NE; Deng C
Oncogene; 1997 Aug; 15(6):685-90. PubMed ID: 9264409
[TBL] [Abstract][Full Text] [Related]
8. Klf10 induces cell apoptosis through modulation of BI-1 expression and Ca2+ homeostasis in estrogen-responding adenocarcinoma cells.
Hsu CF; Sui CL; Wu WC; Wang JJ; Yang DH; Chen YC; Yu WC; Chang HS
Int J Biochem Cell Biol; 2011 Apr; 43(4):666-73. PubMed ID: 21262377
[TBL] [Abstract][Full Text] [Related]
9. Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma.
Chang VH; Chu PY; Peng SL; Mao TL; Shan YS; Hsu CF; Lin CY; Tsai KK; Yu WC; Ch'ang HJ
Am J Pathol; 2012 Aug; 181(2):423-30. PubMed ID: 22688058
[TBL] [Abstract][Full Text] [Related]
10. The role of KLF4 in UVB-induced murine skin tumor development and its correlation with cyclin D1, p53, and p21(Waf1/Cip1) in epithelial tumors of the human skin.
Choi WJ; Youn SH; Back JH; Park S; Park EJ; Kim KJ; Park HR; Kim AL; Kim KH
Arch Dermatol Res; 2011 Apr; 303(3):191-200. PubMed ID: 21132436
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
[TBL] [Abstract][Full Text] [Related]
12. Klf10 and Klf11 as mediators of TGF-beta superfamily signaling.
Spittau B; Krieglstein K
Cell Tissue Res; 2012 Jan; 347(1):65-72. PubMed ID: 21574058
[TBL] [Abstract][Full Text] [Related]
13. Krüppel-like factor 10 null mice exhibit lower tumor incidence and suppressed cellular proliferation activity following chemically induced liver tumorigenesis.
Heo SH; Jeong ES; Lee KS; Seo JH; Lee WK; Choi YK
Oncol Rep; 2015 Apr; 33(4):2037-44. PubMed ID: 25682863
[TBL] [Abstract][Full Text] [Related]
14. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
17. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
18. Srg3, a mouse homolog of BAF155, is a novel p53 target and acts as a tumor suppressor by modulating p21(WAF1/CIP1) expression.
Ahn J; Ko M; Lee C; Kim J; Yoon H; Seong RH
Oncogene; 2011 Jan; 30(4):445-56. PubMed ID: 20935679
[TBL] [Abstract][Full Text] [Related]
19. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.
Choi BH; Kim CG; Bae YS; Lim Y; Lee YH; Shin SY
Cancer Res; 2008 Mar; 68(5):1369-77. PubMed ID: 18316600
[TBL] [Abstract][Full Text] [Related]
20. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ
Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
